Table 3.
Interventions considered
| Intervention | Assumed Magnitude |
|---|---|
| Reduced Prescribing for Acute Pain | 10% reduction in incidence of prescribing opioids for acute pain |
| Reduced Prescribing for Transitioning Pain | 10% reduction in incidence of prescribing opioids for acute pain that transitions to chronic |
| Reduced Prescribing for Chronic Pain | 10% reduction in incidence of prescribing opioids for chronic pain |
| Drug Rescheduling | 10% reduction in chance of getting prescription renewed |
| Prescription Monitoring Program (PMP) | 15% reduction in incidence of prescribing opioids for acute pain |
| 5% reduction in incidence of prescribing opioids for transitioning pain | |
| 5% reduction in incidence of prescribing opioids for chronic pain | |
| Drug Reformulation | 2.25% reduction in iatrogenic use disorder |
| 2.25% reduction in chance of use disorder via diversion for pain-free non-users | |
| 2.25% reduction in pill-seeking for individuals with SOUD without Rx | |
| Excess Opioid Disposal - Policy 1 | 10% reduction in diversion to pain-free non-users |
| 10% reduction in number of individuals with SOUD without Rx able to be sustained by non-SOUD Rx holders | |
| Excess Opioid Disposal - Policy 2 | 15% reduction in diversion to pain-free non-users |
| 15% reduction in number of individuals with SOUD without Rx able to be sustained by non-SOUD Rx holders | |
| Naloxone Availability - Policy 1 | 5% reduction in overdose mortality |
| Naloxone Availability - Policy 2 | 15% reduction in overdose mortality |
| Naloxone Availability - Policy 3 | 30% reduction in overdose mortality |
| Pharmacotherapy | 25% increased likelihood of entering pharmacotherapy |
| Psychosocial Treatment | 10% increased likelihood of desistance |
| Syringe Exchange | 10% reduction in infection mortality |
Abbreviations: Rx = prescription; SOUD = severe opioid use disorder